COMBINATI

Dropworks

This company develops digital PCR instruments for highly sensitive nucleic acid quantification for life science and diagnostic researchers.

Stilla Technologies

This company develops digital PCR instruments and genetic analysis tests for researchers and clinicians in the pharmaceutical, clinical and life sciences sectors.

PreComb

This company develops a precision oncology platform using patient-derived microtumour models and automated analysis to predict drug responses for biopharmaceutical firms and clinical institutions.

Palamedrix

This company develops DNA nanotechnology and biosensor platforms for multi-omic detection and proteomic analysis for biopharmaceutical and academic research markets.

QuantaLife

This company develops digital polymerase chain reaction systems for laboratories to identify and quantify DNA molecules for genetic analysis and disease diagnosis.

DropCode

This company develops a droplet-microfluidics platform and DNA barcoding to provide protein analysis data for biotechnology and pharmaceutical organisations.

Proteomics

This company develops automated benchtop instruments for multiplexed protein analysis to assist researchers in the biotechnology and pharmaceutical industries.

Genetic Sequencing

This company develops nanopore-based technology for DNA sequencing to support researchers and clinicians in medical diagnostics and genomic analysis.